Congressional Hearing on Saccharin Ban Moratorium (1977)
July 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing addresses whether the federal government should continue to allow the sale of saccharin in food and drugs while scientific studies on its potential cancer risks are evaluated.
Potentially affected actors named in the source documents. Mention is not a position.
Food and Drug Manufacturers
These entities are affected by the legal status of saccharin as a permitted or banned additive in their products.
Consumers
Consumers are affected by the availability of products containing saccharin and the regulatory determination of its safety.
Last recorded activity July 20, 2026.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on June 27, 1977, by the Subcommittee on Health and the Environment.
- H.R. 7753 proposes an 18-month moratorium on the ban of saccharin as a food, drug, and cosmetic additive.
- The legislation directs the Institute of Medicine to conduct a one-year review of the toxicity and carcinogenicity of food additives.
- The review is tasked with determining if animal cancer studies can accurately predict human health effects.
- The review is tasked with determining if regulatory decisions should weigh the risks and benefits of food additives.
- H.R. 5166 proposes amending the Federal Food, Drug, and Cosmetic Act to authorize risk-benefit evaluations for food additives.
- The bills seek to allow the continued marketing of saccharin until the scientific evaluation is completed.
Frequently Asked Questions
What is the purpose of these bills?
Who would conduct the safety review?
Why It Matters
The hearing addresses whether the federal government should continue to allow the sale of saccharin in food and drugs while scientific studies on its potential cancer risks are evaluated.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Risk-Benefit Analysis Debate
The hearing highlights a pivotal moment in regulatory history where Congress considered mandating risk-benefit analysis for food additives rather than relying solely on toxicity findings.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance85How much this matters to a regular citizen
- Controversy75Intensity of disagreement among stakeholders
- Entertainment20Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools